Shares of precious-metals miner Hecla Mining got a boost from commodities, but also provided a strong operating update and outlook.
The "Middle East and Africa Aesthetic Medical Laser Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis ByType, Application, and End-User" report has been added to ResearchAndMarkets.com's offering.
FOX News Channel (FNC) has signed KTTV-TV (FOX) investigative reporter Bill Melugin as a national correspondent, announced Jay Wallace, president and executive editor of FOX News Media. Melugin will begin his new role on May 3rd and will be based in FNC’s Los Angeles bureau.
The U.S. National Highway Traffic Safety Administration (NHTSA) said on Monday it was investigating a Texas crash on Saturday that left two dead and local police said appeared to have occurred with no one in the driver's seat. Tesla had no immediate comment. The crash occurred as scrutiny is increasing over Tesla's semi-automated Autopilot driving system following recent crashes.
Joaquim Silva e Luna, the new chief executive of Brazil's Petrobras, will look to respect the company's current pricing policy and keep investing in deepwater assets, he said at his swearing-in ceremony on Monday. The comments by the former army general signaled that Petrobras' incoming administration will attempt to maintain some form of continuity with the policies of the previous administration, which generally won market plaudits. While Luna's comments regarding fuel pricing were not entirely novel, Brazil-listed preferred shares in the company rose roughly 2.6% over the course of his brief speech, and were trading up 3.9% at mid-day, among the biggest gainers on Brazil's benchmark Bovespa equities index.
Whiteford, Taylor & Preston announced that David S. Panzer has joined the firm’s DC office and will co-head Whiteford’s Government Contracts practice.
The V Foundation Announces New Category of V Scholar Grant for Black/African American Researchers
The talks were apparently brokered by the Iraqi PM
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Marlin Business Services Corp. (NASDAQ: MRLN) to HPS Investment Partners LLC for $23.50 per share is fair to Marlin shareholders.
The "South and Central America Analysis Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type; Application; Source, and Country" report has been added to ResearchAndMarkets.com's offering.
Mr Schleicher said the defendant engaged in assault, not policing
Climate activist Greta Thunberg said on Monday her foundation will donate 100,000 euros ($120,290) to support more equitable global COVID-19 vaccine distribution. Thunberg had earlier https://www.reuters.com/business/environment/activist-greta-thunberg-skip-un-climate-conference-scotland-2021-04-09 hit out at nations she said were unwilling to share vaccines with those that have little access to the drugs.
Let's have a look at Philippe Laffont's top 5 stocks for 2021.New York, NY, April 19, 2021 (GLOBE NEWSWIRE) -- Belgian-born, New York-based billionaire Philippe Laffont has been busy in Q1. After scoring 65% gain last year, the hedge fund manager of Coatue Management, with over 26 billion in assets, has doubled down on technology stocks that are anticipated to benefit from the economic reopening. In a statement, Mr. Laffont says, “I used to think it was all stock picking. The truth is, risk management is half the battle. Portfolio management is like poker, you don’t always get perfect cards, and you need to manage your stack. My risk management is broken down between rules I never break and principles that reinforce good habits.” Similar to star fund manager Cathie Wood of Ark Invest fame, Mr. Laffont’s core investment thesis revolves around innovation. He says, “only 10% of S&P companies grow 20% or more. They have 100 Billion of cash. Meanwhile, the other 90% have 1.8 Trillion in net debt. All the growth companies have the cash, the old companies (have) the debt. Good luck competing against the innovators!” Philippe Laffont has disclosed 76 total holdings in Coatue’s latest filings. The most recent portfolio value is calculated to be $ 26,732,667,000 USD. Actual Assets Under Management is this value plus cash which is not readily disclosed on Portfolio Insider. Let’s start examining billionaire Philippe Laffont’s top 5 stocks for 2021, representing almost 30% of the Coatue portfolio. 1. The Walt Disney This technology investing billionaire raised his position by 17% in Walt Disney, plowing over $2 billion into the stock amid hopes the world’s largest entertainment company is likely to benefit from vaccine rollout and economic reopening. Its flagship streaming alternative to Netflix named Disney+ has already gained significant traction by garnering more than 100 million paying subscribers within a short span of 16 months. To be sure, Disney now expects to see between 230 million and 260 million subscribers on Disney+ by 2024, which basically triples its prior expectation of reaching between 60 million and 90 million subscribers by 2024. Despite slower than expected Q4 stock performance, Investors look optimistic about its streaming platform, which exceeded the 100 million subscribers milestone only after launching the streaming service one and a half years ago. “The enormous success of Disney Plus ... has inspired us to be even more ambitious, and to significantly increase our investment in the development of high-quality content,” CEO Bob Chapek said. “In fact, we set a target of [more than] 100 new titles per year, and this includes Disney Animation, Disney Live-Action, Marvel, Star Wars, and National Geographic.” Further bolstering the investment thesis for Walt Disney Co. (DIS) is our research showing at least 4,359 institutional owners and shareholders. These institutions hold a total of 1,352,061,191 shares at the time of this writing. The Largest shareholders include Vanguard Group Inc, BlackRock Inc., and others, 2. PayPal Holdings Shares of PayPal are up 164.8% in the past 12 months, but the pace of growth could depend on its wager into Bitcoin (BTC.) PayPal is a long-running favorite stock holding of Coatue Management. Mr. Laffont’s firm first initiated a position in PayPal in 2016 and added to its existing stake recently. PayPal Holdings Inc announced that it has started allowing U.S. consumers to use their cryptocurrency holdings to pay at millions of its online merchants globally, a move that could significantly boost the utility use of digital assets in everyday commerce. Despite easing social distancing policies, the payment processor's fundamentals look strong. The company’s strategy of expanding crypto services is among the biggest catalysts for revenue growth projections. Perhaps Mr. Laffont has wagered over $1.6 billion of his firm's capital by betting on Its crypto revenues expectation to cross the billion level next year. Portfolio Insider has tracked at least 3,771 institutional investors holding at least a total of 1,181,492,406 shares. 3. Tesla The shares of the world’s largest electric vehicle manufacturer Tesla, boasted an annual increase of 625.03%, only bested by Bitcoin soaring over 800% in the past year. Further solidifying the shift toward inflation inverse treasury management, Tesla announced it has bought $1.5 billion worth of bitcoin. In a statement, the EV company said it bought bitcoin for “more flexibility to further diversify and maximize returns on our cash.” The self described “Technoking” Elon Musk disclosed that it is now possible to buy Tesla vehicles in the U.S. with bitcoin. In a public statement, the visionary said, “Pay by Bitcoin capability will be available outside the US later this year.” Last year, Tesla was the biggest contributor to hedge fund Tiger cubs, with among the best returns in the last two decades. In Q4, the New York-based hedge fund slashed its stake by 30% in Tesla to 5.68% of the overall portfolio. The stake sale represents Philippe Laffont’s strategy of capitalizing on a massive share price run. Tesla's stock price grew close to 700% during the pandemic year. Analysts generally agree the future fundamentals of Mr. Musk’s electric vehicle manufacturer look strong. This is because of the robust demand for self driving autonomous cars across the world. Tesla just reported first-quarter vehicle production and delivery numbers for 2021. In total, it delivered 184,800 vehicles and produced 180,338 cars. Professional analysts were expecting Tesla to deliver around 168,000 vehicles during this period, according to estimates compiled by Portfolio Insider. Leading analyst Philippe Houchois from Jeffries said in a note, “Legacy-free 30-50% net growth and 2-digit margin potential still support high multiples…Tesla still leads on multiple fronts, from software to design-to-manufacture, speed of execution and direct selling.” 4. Square Inc Philippe Laffont’s hedge fund is doubling down big on fintech payments holding over $1.3 billion in shares of Square (SQ.) Coatue Management raised a position in Square by 11% during Q4 to 4.99% of the overall portfolio. Billionaire Jack Dorsey’s Square has delivered over 400% returns in the past 12 months as it capitalizes on touchless payments and small business loans. Besides Q1 performance, market analysts quoted on Portfolio Insider are calling it a long-term bargain. Oppenheimer analyst Jed Kelly provided a $280 price target to Square stocks amid strong revenue growth projections. “We are incrementally bullish on management’s strategy to invest in its sales force to move upstream and target more mid-market sellers (more than $500,000),” Kelly said. “As Square attracts more mid-market sellers, we believe it can create a dynamic marketing platform by combining both cash/seller ecosystems through Boost,” he added in a statement on Portfolio Insider. 5. Sunrun Sunrun Inc. (RUN) has 849 institutional owners besides Mr. Laffont and in total, they hold at least 219,088,428 shares. Billionaire Philippe Laffont first initiated a position in a residential solar energy systems provider during the third quarter and increased his stake by 126% to 4.85%, according to data on Portfolio Insider. Sunrun stock is up approximately 502% in the last 12 months. Goldman Sachs analyst Brian Lee was quoted with a $70 price target on Sunrun, initiating a buy rating. "We believe U.S. solar demand is back to, if not actually trending above, prior expectations for growth before the onset of the pandemic in early 2020," said the Goldman Sachs analyst statement on Portfolio Insider. "Our ongoing channel checks with downstream distributors and installers also resonate with our expectations that demand heading into 2021 remains strong." Press Contact: PortfolioInsider.com Portfolio Insider Brian Schwartz email@example.com New York, NY, United States Content Disclaimer: The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about. DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.
BURBANK, CA, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), reported today its financial results from fiscal year 2020 in its annual filing where the Company reported over $1 million in revenue. In addition, the new management team released the following statement regarding the filing: “Of course, 2020 was a transformative year for Quanta, Inc. including my appointment as CEO and our reverse merger with my pharmaceutical research company Medolife in December 2020, forming Medolife Rx,” said Medolife CEO Dr. Arthur Mikaelian. “While these results are mostly derived from the previous management team, I am proud to share that we continued to generate revenue at almost the same pace as 2019 despite the COVID-19 pandemic. More importantly, since my appointment, we took imperative steps toward cleaning up some of the outstanding liabilities and the outflow that was happening. If you look at some of our expenses as they relate to percentage of sales, you will see that we are creating a more efficient Company on the consumer wellness side, while we continue to pursue our pharmaceutical initiatives, which we believe hold a large amount of unlocked value for our shareholders.” “In recent months we have made strategic announcements on some of the amazing clinical research we have conducted on our lead drug candidate Escozine® where we are seeking product registration in the Dominican Republic (DR) and are working on a New Investigational Drug submission (IND) with the US Food and Drug Administration (FDA). Beyond these clinical programs, which are showing great promise, we have monetized our proprietary formulation in the form of a nutraceutical product called Immunapen, for which we recently announced a large purchase order. We have focused resources on expanding our scorpion reservation and manufacturing facilities in order to meet both the pharmaceutical and nutritional demand for our products and continue to work with the Ministry of Health in the DR on registration of our products for use as a cancer therapeutic. All of our revolutionary products utilize a patented polarization technology that makes them more efficacious than their known counterparts, building upon a robust intellectual property strategy. These developments are nothing short of exciting and we truly hope that current and future shareholders share in our vision. While on paper 2020 may not seem as amazing as I am suggesting, I see it differently. We are transforming a consumer wellness Company into a fully integrated biopharmaceutical Company with global operations and that does not happen overnight. Every day we make progress toward our mission of changing the way the world perceives healthcare. While I am not able to share much insight beyond this, I can share that the progress we experienced toward the end of 2020 has absolutely continued into 2021 and we look forward to being able to share the fruits of those labors with our shareholders in the near future. Our opportunity has never been greater and we appreciate those who continue to follow our Company and believe in our future,” added Dr. Mikaelian. Medolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products. Medolife Rx was created through the merger of Medolife, a private company founded by Dr. Arthur Mikaelian who pioneered the unlaying polarization technology that makes the Company’s portfolio of pharmaceutical and nutraceutical products so effective, and Quanta, Inc., a direct-to-consumer wellness product portfolio company. The Company’s lead clinical development programs include Escozine®, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company’s polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. The Company has completed preclinical safety and efficacy research on Escozine® and is pursuing product registration and drug approval in various countries, including the United States and throughout Latin America. Through its subsidiary QuantRx, Medolife manufactures and distributes consumer wellness products in high-impact consumer areas such as pain relief, beauty, and general wellness. QuantRx products are designed using Dr. Mikaelian’s polarization technology, which applies advances in quantum biology to increase the potency of active ingredients. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste, and facilitate healthier, more sustainable consumption. Beyond its own clinical and consumer applications, the polarization technology used by Medolife and its subsidiaries has many potential applications. From potentiating bio-ingredients, to producing more-effective carbon-trapping plants, to transformative anti-aging solutions, Medolife has the opportunity to upend how commercial and pharmaceutical products are made and increase their benefits, while decreasing their chemical concentration. Forward-Looking Statements Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management including statements regarding the Company's expected results of operations or liquidity; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance; and statements of management's goals and objectives and other similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "we believe," "we intend," "may," "will," "should," "could," and similar expressions. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Contacts: Phil Sands https://ir.quantrx.com/ 818-659-8052 Kyle Porter firstname.lastname@example.org 858-264-6600
JOHNS CREEK, Ga., April 19, 2021 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries, today provides an update on projected timing for announcement of its 2020 financial results and filing of its 10-K. The Company expects to announce its earnings the week of April 26, 2021. An announcement will be made prior to the release of 2020 financials with details for an investor call to review the results. Ebix also expects to file its fiscal 2020 Form 10-K with the SEC the week of April 26th. About Ebix With a "Phygital” strategy that combines 320,000 physical distribution outlets (pre-COVID-19) in many Southeast Asian Nations (“ASEAN”) countries, to an Omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio encompasses leadership in areas of domestic & international money remittance, foreign exchange (Forex), travel, pre-paid & gift cards, utility payments, lending, software solutions for lending and wealth management etc. in India and other markets. EbixCash’s Forex operations have emerged as a leader in India’s airport Foreign Exchange business with operations in 20 international airports including Delhi, Mumbai, Bangalore, Hyderabad, Chennai and Kolkata, conducting over $4.8 billion in gross transaction value per year (pre-COVID-19). EbixCash’s inward remittance business in India conducts approximately $5 billion gross annual remittance business (pre-COVID-19) and is the clear market leader. EbixCash, through its travel portfolio of Via and Mercury, is one of Southeast Asia’s leading travel exchanges with more than 200,000 agents, 25 branches and over 9,800 corporate clients, combined processing an estimated $2.5 billion in gross merchandise value per year (pre-COVID-19). EbixCash’s Financial Technology solutions are today deployed across prestigious financial institutions and Banks in 44 countries. For more information, visit the Company’s website at www.ebixcash.com. With 50+ offices across 6 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries. In the Insurance sector, Ebix’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also, providing Software-as-a-Service ("SaaS") enterprise solutions in the area of CRM, front-end & back-end systems, outsourced administration and risk compliance services, around the world. For more information, visit the Company’s website at www.ebix.com. FORWARD LOOKING STATEMENTS This press release contains certain statements that are “forward-looking” statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based upon current expectations and include all statements that are not historical statements of fact and those regarding the intent, belief or expectations, including, without limitation, statements that are accompanied by words such as “will,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “estimates,” “seeks,” “may” or other similar words, phrases or expressions and variations or negatives of these words. Readers of this press release should understand that these statements are not guarantees of performance or results. Many risks and uncertainties could affect actual results and cause them to vary materially from the expectations contained in the forward-looking statements. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the potential impacts of RSM’s resignation; the ability to, as well as the ability to timely, engage a new independent registered public accounting firm; the risk of litigation or regulatory action arising from these matters, from the failure to timely file the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Annual Report”) or from the resignation of the RSM; the timing of the review by, and the conclusions of, the Company’s new independent auditor regarding these matters and its impact on the financial statements; possible default by the Company under its credit facility; the ability of the Company to remediate any material weaknesses in internal control over financial reporting; potential reputational damage that the Company may suffer as a result of these matters or the resignation of RSM; the impact of these matters and the resignation of RSM on the value of the Company’s stock; and the risk that the filing of the Annual Report will take longer than anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statement made by us speaks only as of the date of this report. Unless required by law, the Company does not undertake to release publicly any revisions to these forward-looking statements to reflect future events or circumstances or to reflect the occurrence of unanticipated events. Contact: Darren JosephIR@ebix.com or +1 678 281 2027David Collins or Chris EddyCatalyst Global + 1 212-924-9800 or email@example.com
AM Best will host a complimentary webinar exploring the state of the medical professional liability (MPL) insurance market on Thursday, May 13, 2021, at 10:00 a.m. (EDT). AM Best analytic personnel and insurance industry leaders will examine MPL insurers’ underwriting and operating results, pandemic-related challenges in the healthcare industry, and regulatory and industry developments. AM Best has a negative market segment outlook on the MPL insurance market, as explained in AM Best’s annual report on MPL insurers. This segment could be facing one of its most difficult periods in the last decade or more, partly due to the COVID-19 pandemic. During the event, the panel will discuss the present day and potential future impacts of the pandemic on MPL insurers. Register now at www.ambest.com/webinars/MPLI21.
NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Mackinac Financial Corporation (NASDAQ: MFNC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Nicolet Bankshares, Inc. Under the terms of the merger agreement, Mackinac shareholders will receive 0.22 shares of Nicolet’s common stock and $4.64 for each share of Mackinac they own. If you are a Mackinac shareholder, click here to learn more about your rights and options. Athene Holding Ltd. (NYSE: ATH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Apollo Global Management, Inc. Under the terms of the transaction, each outstanding Class A common share of Athene will be exchanged for a fixed ratio of 1.149 shares of Apollo common stock. If you are an Athene shareholder, click here to learn more about your rights and options. Protective Insurance Corporation (NASDAQ: PTVCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Progressive Corporation for $23.30 in cash for each share of Protective Class A and Class B common stock. If you are a Protective shareholder, click here to learn more about your rights and options. Extended Stay America, Inc. (NASDAQ: STAY) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a joint venture between funds managed by Blackstone Real Estate Partners and Starwood Capital Group for $19.50 per share in cash. If you are an Extended Stay shareholder, click here to learn more about your rights and options. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email firstname.lastname@example.org or email@example.com. Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLPDaniel Sadeh, Esq.Zachary Halper, Esq.(212) firstname.lastname@example.org@halpersadeh.com https://www.halpersadeh.com
CUPE 458 welcomed 18 new members who work as fitness and recreation instructors in the District of Kent last week. Following a representation vote held in December, the Labour Board recently certified these workers as members of CUPE 458.
The partnership aims to create a simplified crypto on-ramp and asset trade automation solution for new investors and tradersUAE, April 19, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire) - Sheesha Finance (https://sheesha.finance), the first comprehensive DeFi solution for investors to easily access a variety of projects while solving issues surrounding locked crypto assets, today announced their partnership with TeraBlock (https://terablock.ai), a trade automation exchange for cryptocurrencies that personalizes each user’s experience through machine learning. The partnership will leverage Sheesha’s unique DeFi staking model and TeraBlock’s machine learning technology to simplify the way people enter the crypto ecosystem as well as increasing and promoting the use of DeFi services instead of traditional finance. With the global cryptocurrency market cap over $2 trillion, more and more investors are taking notice and investing their funds into the space. However, these new investors quickly learn that the crypto industry comes with the risk of high market volatility. In addition, Decentralized Finance (DeFi) can often be too complex for a casual investor to understand. Sheesha Finance and TeraBlock aim to overcome these barriers by providing new investors resources and guidance on investing and managing their cryptocurrency portfolios. “We are very excited about the partnership with TeraBlock and want to help regular traders as well as those interested in exploring and entering the cryptocurrency ecosystem,” said Saeed Hareb Al Darmaki, Founder at Sheesha Finance. “TeraBlock has strong foundations as a leading technology company specializing in using machine learning for trade automation and their innovation combined with our DeFi mutual fund will completely change how people manage their cryptocurrency portfolios.” “Cryptocurrencies finally have the right attention from the mainstream media and the leaders of financial markets,” said Shivam Tandon, founder and CEO at TeraBlock. “There will be millions of people looking to enter the crypto ecosystem in the near future. TeraBlock’s partnership with Sheesha will create opportunities for new investors entering the market by providing resources that will help them explore decentralized finance without difficulty, and through the process they will learn how to safely manage their investment portfolios.” Sheesha Finance is dedicated to bringing full transparency and integrity to DeFi. Sheesha ensures its ecosystem participants can fully benefit by maximizing their exposure to various DeFi projects and rewards. Sheesha Finance is the first DeFi mutual fund that rewards investors of any size, from small to large ticket holders, with unlimited DeFi tokens from a diversified portfolio of projects. Earlier this month, Sheesha Finance successfully raised over $9.44 million in two weeks through an innovative token distribution mechanism, known as a Liquidity Generation Event (LGE). The founding team bootstrapped Sheesha Finance, and will eventually hand over the control of the ecosystem to its native token holders through a Decentralized Autonomous Organization (DAO). For more information about the Sheesha Finance and TeraBlock partnership, join the Sheesha Finance official Telegram group. About Sheesha Finance Sheesha Finance (https://sheesha.finance/) is a one-stop-shop for DeFi projects, similar to a DeFi mutual fund. Sheesha aims to solve locked cryptocurrency inaccessibility issues in DeFi by creating easily convertible assets that can be freely utilized to maximize participant rewards and gain exposure to existing and upcoming DeFi projects. After launch, Sheesha Finance plans to maintain market transparency and integrity by giving control to the native token holders through a Decentralized Autonomous Organization (DAO). Twitter - Medium - Telegram - Gitbook - LinkedIn About TeraBlock TeraBlock (https://terablock.ai) is a trade automation exchange for cryptocurrency portfolio management that personalizes each user’s experience through machine learning. Their goal is to provide resources for new users to make hard decisions easily when it comes to trading cryptocurrencies. At TeraBlock, investors will be able to purchase cryptocurrency with any card from a bank and manage their assets with trade automation. TeraBlock is essentially an exchange in its simplest form, providing investors the resources they need to trade and invest without hesitation. CONTACT: Media contact: Sheesha@transformgroup.com Sheesha Finance Company contact: Benjamin Leff, COO, email@example.com TeraBlock Company Contact: firstname.lastname@example.org
Group of poachers was fleeing park rangers when they came across herd
Follow latest updates from the Hennepin County Courthouse